-
IUPAC Name:(1R)-1-{[(2S,3R,11bS)-3-ethyl-9,10-dimethoxy-1H,2H,3H,4H,6H,7H,11bH-pyrido[2,1-a]isoquinolin-2-yl]methyl}-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline hydrobromide
Supplier Lead time Price, € Pack Alfa ChemistryShips from: United StatesTo:TBD POA1 gDescription: CAS: 52714-87-1BOC SciencesShips from: United StatesTo:TBD POA1 gDescription: CAS: 52714-87-1For a custom pack size or bulk
please drop us a line:Enquire -
![]()
-
IUPAC Name:2,6-dibromophenyl (3S)-2-[3-(3,4-dihydroxyphenyl)propanoyl]-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylate
Supplier Lead time Price, € Pack MedChemExpressShips from: United StatesTo:TBD POA1 mgDescription: Names: PAN endonuclease-IN-2; Product Description: PAN endonuclease-IN-2 (compound T-31) is a PA N endonuclease inhibitor ( IC 50 : 0.15 μM) and antiviral agent with broad-spectrum anti- Influenza activity. PAN is the N-terminal PA subunit of the polymerase-RNA complex and the dependent endonuclease (CEN) active site. PAN initiates RNA replication by promoting cleavage of the RNA strand and allowing the polymerase to begin synthesizing new RNA molecules. PAN endonuclease-IN-2 targets both the influenza HA and RdRp complexes, thereby interfering with viral entry into host cells and viral replication .; Target: Influenza VirusMedChemExpress EUShips from: SwedenTo:TBD POA1 mgDescription: Names: PAN endonuclease-IN-2; Product Description: PAN endonuclease-IN-2 (compound T-31) is a PAN endonuclease inhibitor (IC50: 0.15 μM) and antiviral agent with broad-spectrum anti- Influenza activity. PAN is the N-terminal PA subunit of the polymerase-RNA complex and the dependent endonuclease (CEN) active site. PAN initiates RNA replication by promoting cleavage of the RNA strand and allowing the polymerase to begin synthesizing new RNA molecules. PAN endonuclease-IN-2 targets both the influenza HA and RdRp complexes, thereby interfering with viral entry into host cells and viral replication; Target: Influenza VirusFor a custom pack size or bulk
please drop us a line:Enquire -
![]()
-
IUPAC Name:1-[(2-chlorophenyl)methyl]-4-[(9S)-15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaene-10-carbonyl]pyridin-1-ium bromide
Supplier Lead time Price, € Pack MedChemExpressShips from: United StatesTo:TBD POA1 mgDescription: Names: AChE-IN-49; Product Description: AChE-IN-49 (Compd (S)-7g) is an acetylcholinesterase (AChE) inhibitor, with an IC 50 of 0.0003 μM .; Target: Cholinesterase (ChE)MedChemExpress EUShips from: SwedenTo:TBD POA1 mgDescription: Names: AChE-IN-49; Product Description: AChE-IN-49 (Compd (S)-7g) is an acetylcholinesterase (AChE) inhibitor, with an IC50 of 0.0003 μM; Target: Cholinesterase (ChE)For a custom pack size or bulk
please drop us a line:Enquire -
![]()
-
IUPAC Name:5-bromo-6-{[1-(4-chlorophenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl]sulfonyl}-1,3-dimethyl-2,3-dihydro-1H-1,3-benzodiazol-2-oneFor a custom pack size or bulk
please drop us a line:Enquire -
![]()
-
IUPAC Name:5-bromo-6-{1-[(3,4-diethoxyphenyl)methyl]-6,7-diethoxy-1,2,3,4-tetrahydroisoquinoline-2-carbonyl}-1,3-dimethyl-2,3-dihydro-1H-1,3-benzodiazol-2-oneFor a custom pack size or bulk
please drop us a line:Enquire -
![]()
-
IUPAC Name:(1S,14S)-19-bromo-9,20,21,25-tetramethoxy-15,30-dimethyl-7,23-dioxa-15,30-diazaheptacyclo[22.6.2.2³,⁶.1⁸,¹².1¹⁴,¹⁸.0²⁷,³¹.0²²,³³]hexatriaconta-3,5,8(34),9,11,18,20,22(33),24(32),25,27(31),35-dodecaene
Supplier Lead time Price, € Pack Targetmol Chemicals IncShips from: United StatesTo:30 days 1,520 Description: Bromotetrandrine is an P-glycoprotein inhibitor, which were developed and coadministered with chemotherapeutic drugs to overcome the effect of efflux pumps thus enhancing the chemosensitivity of therapeutics.; CAS: 62067-29-2MedChemExpressShips from: United StatesTo:TBD POA1 mgDescription: Names: Bromotetrandrine; 5-Bromotetrandrine; BrTet; W198; Product Description: Bromotetrandrine is a potent inhibitor of P-glycoprotein (P-gp)-mediated multidrug resistance ( MDR ). Bromotetrandrine shows significant MDR reversal activity in vitro and in vivo, which may be related to the inhibition of P-gp overexpression and the increase in intracellular accumulation of anticancer agents. Bromotetrandrine is a brominated derivative of tetrandrine, which is promising for MDR modulator for tumor assessment .; Target: Drug Derivative;P-glycoprotein; CAS: 62067-29-2MedChemExpress EUShips from: SwedenTo:TBD POA1 mgDescription: Names: Bromotetrandrine; 5-Bromotetrandrine; BrTet; W198; Product Description: Bromotetrandrine is a potent inhibitor of P-glycoprotein (P-gp)-mediated multidrug resistance (MDR). Bromotetrandrine shows significant MDR reversal activity in vitro and in vivo, which may be related to the inhibition of P-gp overexpression and the increase in intracellular accumulation of anticancer agents. Bromotetrandrine is a brominated derivative of tetrandrine, which is promising for MDR modulator for tumor assessment; Target: Drug Derivative;P-glycoprotein; CAS: 62067-29-2For a custom pack size or bulk
please drop us a line:Enquire -
![]()
-
IUPAC Name:2-(7-{4-[(3Z)-5-bromo-3-[(3-bromo-4-hydroxy-5-methoxyphenyl)methylidene]-2-oxo-2,3-dihydro-1H-indol-1-yl]butoxy}-6-methoxy-1-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl)-N-(1,3-thiazol-2-yl)acetamide
Supplier Lead time Price, € Pack MedChemExpressShips from: United StatesTo:TBD POA1 mgDescription: Names: PCSK9-IN-24; Product Description: PCSK9-IN-24 (Compound OY3) is a compound that targets PCSK9 . PCSK9-IN-24 reduces PCSK9 levels and increases LDL uptake and may be used in atherosclerosis research .; Target: PCSK9; CAS: 2974496-96-1MedChemExpress EUShips from: SwedenTo:TBD POA1 mgDescription: Names: PCSK9-IN-24; Product Description: PCSK9-IN-24 (Compound OY3) is a compound that targets PCSK9. PCSK9-IN-24 reduces PCSK9 levels and increases LDL uptake and may be used in atherosclerosis research; Target: PCSK9; CAS: 2974496-96-1For a custom pack size or bulk
please drop us a line:Enquire -
![]()
-
IUPAC Name:(1S,14S)-19-bromo-9,20,25-trimethoxy-15,30-dimethyl-11-nitro-7,23-dioxa-15,30-diazaheptacyclo[22.6.2.2³,⁶.1⁸,¹².1¹⁴,¹⁸.0²⁷,³¹.0²²,³³]hexatriaconta-3,5,8(34),9,11,18,20,22(33),24(32),25,27(31),35-dodecaen-21-yl benzoate
Supplier Lead time Price, € Pack MedChemExpressShips from: United StatesTo:TBD POA1 mgDescription: Names: Angiogenesis inhibitor 3; Product Description: Angiogenesis inhibitor 3 (compound 8) is a potent angiogenesis inhibitor. Angiogenesis inhibitor 3 inhibits the proliferation of HUVEC and HCT-15 cells, with IC 50 values of 1.00 and 0.71 μM. Angiogenesis inhibitor 3 induces the apoptosis of HUVEC and HCT-15 cells. Angiogenesis inhibitor 3 shows anticancer activity, and suppresses the invasion of cancer cells. Angiogenesis inhibitor 3 inhibits the angiogenesis in zebrafish embryos .; Target: Apoptosis; CAS: 2507759-39-7MedChemExpress EUShips from: SwedenTo:TBD POA1 mgDescription: Names: Angiogenesis inhibitor 3; Product Description: Angiogenesis inhibitor 3 (compound 8) is a potent angiogenesis inhibitor. Angiogenesis inhibitor 3 inhibits the proliferation of HUVEC and HCT-15 cells, with IC50 values of 1.00 and 0.71 μM. Angiogenesis inhibitor 3 induces the apoptosis of HUVEC and HCT-15 cells. Angiogenesis inhibitor 3 shows anticancer activity, and suppresses the invasion of cancer cells. Angiogenesis inhibitor 3 inhibits the angiogenesis in zebrafish embryos; Target: Apoptosis; CAS: 2507759-39-7Targetmol Chemicals IncShips from: United StatesTo:TBD POA1 mgDescription: Angiogenesis Inhibitor 3 (Compound 8) is a potent substance that effectively inhibits the growth of HUVEC and HCT-15 cells, demonstrating IC50 values of 1.00 and 0.71 μM, respectively. It not only induces apoptosis in these cells but also exhibits significant anticancer activity by suppressing cancer cell invasion. Furthermore, this compound successfully inhibits angiogenesis in zebrafish embryos [1].; CAS: 2507759-39-7For a custom pack size or bulk
please drop us a line:Enquire -
![]()
